What to Eat on a GLP-1: What the Evidence Says
2026-11-06 · 6 min read · GLPcompare Editorial
Short answer: no food is banned on a GLP-1, but what you eat matters more than before, because you eat less of it. The most complete guidance is a 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. It advises regular small meals, enough protein, fiber and fluids, minimal alcohol and strength training. This is not personal advice: a registered dietitian or your clinician can adjust it to you, particularly if you have diabetes or kidney disease.
Why it matters
The advisory reports that people on these medicines eat 16% to 39% fewer calories, and that a drop this large and this fast can leave them short of vitamins and minerals, especially below about 1,200 calories a day for women and 1,800 for men. Nutrients it names as a concern are iron, calcium, magnesium, zinc and vitamins A, D, E, K, B1, B12 and C.
It also names signs worth raising with a clinician: fatigue beyond what you expect, excessive hair loss, skin flaking or itching, muscle weakness and poor wound healing.
Foods that can make stomach side effects worse
Stomach side effects are the most common side effects on every GLP-1 label, and they are most likely when you start or move up a dose. The advisory's advice for them:
- Eat smaller meals, more often. It suggests a small breakfast and then small meals every 3 to 4 hours, with enough fluid. Vomiting is more likely after a large meal.
- Avoid fatty foods and high-fiber foods in the first days of treatment, if nausea is a problem. It also mentions ginger or peppermint tea.
- Do not skip meals to avoid nausea. The advisory notes nausea often comes in the morning or after long gaps without food, and that not eating can make it worse, which then makes eating harder.
- Build fiber up gradually for constipation, from foods such as prunes and other dried fruit, with enough fluid.
- Keep drinking. Severe vomiting or diarrhea can cause dehydration, and every label carries a warning about acute kidney injury from it.
How much protein?
The advisory says protein can be hard to get enough of because of low appetite and changes in taste, and that needs are not settled. It sets out the ranges below.
| Measure | Figure in the advisory |
|---|---|
| General adult recommended daily allowance | 0.8 g per kg of body weight |
| Higher targets proposed during active weight loss | 1.2 to 1.6 g per kg |
| Should not fall below | 0.4 to 0.5 g per kg |
| Avoid prolonged intake at or above | 2 g per kg |
| A simpler target it offers | 80 to 120 g a day (16% to 24% of energy on 2,000 calories) |
| A more exact one, which needs a body composition measure | 1.5 g per kg of lean body mass |
For people with obesity it notes that using actual body weight can overstate what is needed, and that there is no consensus on the best way to set the figure. If you have kidney disease, ask your clinician first.
Protein alone is not enough. The advisory says increased protein intake is likely inadequate to preserve muscle without structured strength training.
Muscle loss and strength training
Some of the weight lost is muscle. The advisory cites modeling suggesting that, without structured strength training, muscle makes up 10% to 15% of the weight lost in women and 20% to 25% in men. It recommends strength training alongside enough protein to preserve muscle and bone.
What is food noise, and do these medicines quiet it?
"Food noise" is what people call constant thinking about food. It began as a word people used, not a medical term: a 2023 review described the reports of it easing on GLP-1s as anecdotal. Researchers published a questionnaire to measure it only in 2025, and they say more research is needed on its clinical use. So many people describe it, and the joint advisory reports that cravings often fall, but it is not yet something a label or a pivotal trial reports as a result.
Can you drink alcohol on a GLP-1?
Alcohol on a GLP-1 has its own guide. In short: the FDA labels for these medicines do not set an alcohol limit. The advisory says alcohol may worsen nausea and reflux and should be minimized. It also reports that many people find their cravings for alcohol, sugary food and fatty food fall on these medicines. If you have diabetes, ask your clinician about alcohol with your other medicines.
What the labels themselves say
The FDA labels are short on food, and they differ by product:
- Weight-loss labels. Zepbound, Wegovy and Foundayo are approved alongside a reduced-calorie diet and more physical activity. The Wegovy injection can be taken with or without meals, and Foundayo with or without food.
- Semaglutide tablets. The Wegovy pill and Rybelsus and Ozempic tablets are taken once a day on an empty stomach in the morning, with up to 4 ounces of water and no other drink. Their labels say to wait at least 30 minutes before eating, drinking or taking other oral medicines.
Do you need supplements?
The advisory says they can be considered for nutrients at risk, such as vitamin D, calcium, B12 or a multivitamin, at appropriate doses and tailored to each person. That is different from the products sold as "natural GLP-1", which contain no GLP-1 drug: see what the evidence says about them.
Common questions
What if I have no appetite? The advisory recommends regular small meals at consistent times rather than long gaps, with enough protein and fluid. Tell your clinician if you are eating very little: it names large, rapid calorie reductions as the cause of nutrient shortfalls.
Why does food taste different? The advisory reports food aversions, sometimes severe, typically when starting treatment and with dose increases. It says the reports of less enjoyment of taste are so far anecdotal.
Do I need a dietitian? The advisory lists counseling from a registered dietitian among the supports that help, and notes the STEP 1 and SURMOUNT-4 trials made it available. It adds that this kind of care is not always available.
Sources
The dietary guidance here is from the joint advisory, published in Obesity in 2025. Side effect rates and warnings are from each medicine's FDA label, on its side effects page. This article is information, not medical advice.